Results 151 to 160 of about 3,330,143 (311)

Prediction of recurrence free survival of head and neck cancer using PET/CT radiomics and clinical information [PDF]

arXiv
The 5-year survival rate of Head and Neck Cancer (HNC) has not improved over the past decade and one common cause of treatment failure is recurrence. In this paper, we built Cox proportional hazard (CoxPH) models that predict the recurrence free survival (RFS) of oropharyngeal HNC patients.
arxiv  

Soft-NeuroAdapt: A 3-DOF Neuro-Adaptive Patient Pose Correction System For Frameless and Maskless Cancer Radiotherapy [PDF]

arXiv, 2017
Precise patient positioning is fundamental to successful removal of malignant tumors during treatment of head and neck cancers. Errors in patient positioning have been known to damage critical organs and cause complications. To better address issues of patient positioning and motion, we introduce a 3-DOF neuro-adaptive soft-robot, called Soft ...
arxiv  

Pharmacodynamics and biodistribution of [195mPt]cisplatin(CISSPECT®) in head and neck squamous cell carcinoma

EJNMMI Research
Background Cisplatin- based chemoradiotherapy is a crucial pillar in the treatment of HNSCC. The use of cisplatin comes with high toxicity rates as 35% of patients cannot sustain the planned dose while response is unpredictable.
Reinout H. de Roest, Marijke Stigter van Walsum, Karlijn van der Schilden, Ruud H. Brakenhoff   +3 more
doaj   +1 more source

BCL2 and hsa-miR-181a-5p are potential biomarkers associated with papillary thyroid cancer based on bioinformatics analysis

World Journal of Surgical Oncology, 2019
Background The morbidity of thyroid carcinoma has been rising worldwide and increasing faster than any other cancer type. The most common subtype with the best prognosis is papillary thyroid cancer (PTC); however, the exact molecular pathogenesis of PTC ...
Cong Zhang, Chunrui Bo, Lunhua Guo, Pingyang Yu, Susheng Miao, Xin Gu   +5 more
doaj   +1 more source

Regional chemotherapy with combined drugs in cancer of the head and neck [PDF]

, 1976
William L. Donegan, Phyllis Braudy Harris   +1 more
openalex   +1 more source

Survival Prediction in Head and Neck Cancer: Impact of Tumor and Patient Specific Characteristics [PDF]

, 2012
Head and neck cancer accounts for almost 5% of all malignant tumors in the Netherlands. The most up‐todate Dutch Cancer Registry (NCR) database from 2009 reported 2878 new patients with an invasive carcinoma of the lip, oral cavity, pharynx and ...
Datema, F.R. (Frank)
core  

Enhanced Survival Prediction in Head and Neck Cancer Using Convolutional Block Attention and Multimodal Data Fusion [PDF]

arXiv
Accurate survival prediction in head and neck cancer (HNC) is essential for guiding clinical decision-making and optimizing treatment strategies. Traditional models, such as Cox proportional hazards, have been widely used but are limited in their ability to handle complex multi-modal data.
arxiv  

Preoperative irradiation for head and neck cancer: A prospective study [PDF]

, 1974
Walter Lawrence, Jose J. Terz, Charles C. Rogers, Roger E. King, J. Stuart Wolf, E. Richard King   +5 more
openalex   +1 more source

Factors associated with delay in diagnosis of oral cancers

Cancer Treatment and Research Communications
Background: Oral cancer is one of the ten most common malignancies in the world and approximately 90 % of cases are OSCC. Despite the progress in available treatment modalities, the mortality of patients with OSCC has remained steadily high during the ...
Deepa Swaminathan, Nebu Abraham George, Shaji Thomas, Elizabeth Mathew Iype   +3 more
doaj  

Immunologic evaluation of patients with advanced head and neck cancer receiving weekly chemoimmunotherapy [PDF]

, 1979
Jacob Zighelboim, Fred Dorey, Neil H. Parker, T. C. Calcaterra, Paul H. Ward, John L. Fahey   +5 more
openalex   +1 more source